Skip to search formSkip to main contentSkip to account menu

bleomycin/cisplatin protocol

Known as: BP, Bleomycin/Cisplatin, BLEO/CDDP 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To document safety for use, through recording changes in blood pressure and pulse rate, after administering 3.6 ml of a… 
2011
2011
Bone metastases in advanced breast cancer patients remains a significant treatment challenge. Bisphosphonates are now a routine… 
2007
2007
The rat streptozotocin (STZ)-induced diabetes model is widely used to investigate the pathogenesis of diabetic nephropathy… 
Highly Cited
2006
Highly Cited
2006
To develop stimuli-responsive ultrathin polymer films on a solid substrate, a novel photo-cross-linkable polymer with both… 
2000
2000
Objective: To examine prospectively the effects of antihypertensive therapy on office blood pressure (BP) and home BP, in a large… 
1999
1999
Between January and December 1996, we observed 64 children (mean age 8.3 years range 4.2 to 11.2 years) who required dialysis for… 
1999
1999
BACKGROUND It has been known since 1953 that pre-exposure to less than +1 Gz will reduce subsequent +Gz-tolerance. With few… 
Highly Cited
1998
Highly Cited
1998
Unopposed actions of vasoconstrictors, such as angiotensin, play an important role in the effects of chronic nitric oxide… 
1994
1994
The preventive effect of betamipron (N-benzoyl-3-propionic acid: BP) on the renal uptake and nephrotoxicity of carbapenems…